Article in Neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Hayley F ThorntonFrom the Department of Clinical Neurosciences (H.F.T.), Cumming School of Medicine, University of Calgary, Alberta, Canada; Department of Neurology (S.C.L., R.B.), and UCSF Weill Institute for Neurosciences (S.C.L., R.B.), Department of Neurology, University of California, San Francisco; Buck Institute for Research on Aging (S.C.L.), Novato, CA; Department of Neurology (J.W.), University of Pittsburgh Medical Center, PA; Department of Neurology (M.A.O.N.), Brigham and Women's Hospital, Boston, MA; Division of Neurology (E.B.), Department of Medicine, University of Toronto; and Krembil Brain Institute (E.B.), University Health Network, Toronto, Ontario, Canada.ORCID 0000-0003-0404-5380
Sara C LaHueFrom the Department of Clinical Neurosciences (H.F.T.), Cumming School of Medicine, University of Calgary, Alberta, Canada; Department of Neurology (S.C.L., R.B.), and UCSF Weill Institute for Neurosciences (S.C.L., R.B.), Department of Neurology, University of California, San Francisco; Buck Institute for Research on Aging (S.C.L.), Novato, CA; Department of Neurology (J.W.), University of Pittsburgh Medical Center, PA; Department of Neurology (M.A.O.N.), Brigham and Women's Hospital, Boston, MA; Division of Neurology (E.B.), Department of Medicine, University of Toronto; and Krembil Brain Institute (E.B.), University Health Network, Toronto, Ontario, Canada.ORCID 0000-0003-2396-7663
Riley BoveFrom the Department of Clinical Neurosciences (H.F.T.), Cumming School of Medicine, University of Calgary, Alberta, Canada; Department of Neurology (S.C.L., R.B.), and UCSF Weill Institute for Neurosciences (S.C.L., R.B.), Department of Neurology, University of California, San Francisco; Buck Institute for Research on Aging (S.C.L.), Novato, CA; Department of Neurology (J.W.), University of Pittsburgh Medical Center, PA; Department of Neurology (M.A.O.N.), Brigham and Women's Hospital, Boston, MA; Division of Neurology (E.B.), Department of Medicine, University of Toronto; and Krembil Brain Institute (E.B.), University Health Network, Toronto, Ontario, Canada.ORCID 0000-0002-2034-8800
Janet WatersFrom the Department of Clinical Neurosciences (H.F.T.), Cumming School of Medicine, University of Calgary, Alberta, Canada; Department of Neurology (S.C.L., R.B.), and UCSF Weill Institute for Neurosciences (S.C.L., R.B.), Department of Neurology, University of California, San Francisco; Buck Institute for Research on Aging (S.C.L.), Novato, CA; Department of Neurology (J.W.), University of Pittsburgh Medical Center, PA; Department of Neurology (M.A.O.N.), Brigham and Women's Hospital, Boston, MA; Division of Neurology (E.B.), Department of Medicine, University of Toronto; and Krembil Brain Institute (E.B.), University Health Network, Toronto, Ontario, Canada.ORCID 0009-0001-1243-0054
Mary A O'NealFrom the Department of Clinical Neurosciences (H.F.T.), Cumming School of Medicine, University of Calgary, Alberta, Canada; Department of Neurology (S.C.L., R.B.), and UCSF Weill Institute for Neurosciences (S.C.L., R.B.), Department of Neurology, University of California, San Francisco; Buck Institute for Research on Aging (S.C.L.), Novato, CA; Department of Neurology (J.W.), University of Pittsburgh Medical Center, PA; Department of Neurology (M.A.O.N.), Brigham and Women's Hospital, Boston, MA; Division of Neurology (E.B.), Department of Medicine, University of Toronto; and Krembil Brain Institute (E.B.), University Health Network, Toronto, Ontario, Canada.
Esther BuiFrom the Department of Clinical Neurosciences (H.F.T.), Cumming School of Medicine, University of Calgary, Alberta, Canada; Department of Neurology (S.C.L., R.B.), and UCSF Weill Institute for Neurosciences (S.C.L., R.B.), Department of Neurology, University of California, San Francisco; Buck Institute for Research on Aging (S.C.L.), Novato, CA; Department of Neurology (J.W.), University of Pittsburgh Medical Center, PA; Department of Neurology (M.A.O.N.), Brigham and Women's Hospital, Boston, MA; Division of Neurology (E.B.), Department of Medicine, University of Toronto; and Krembil Brain Institute (E.B.), University Health Network, Toronto, Ontario, Canada.ORCID 0000-0002-5785-9524
Funding
Sex and Gender Enriched NeurologyR25NS136037 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Riley Marie Browne Bove · 2023 to 2026
$648k
NINDS NIH HHS R25 NS136037
6 · The paper itself
Abstract
The influence of sex and gender on neurologic disease has become increasingly recognized in science and medicine. This is evident across a woman's lifespan especially during periods of hormonal transitions. Leaders in neurology have advocated for the importance of sex and gender-enriched clinical care, education, and research. The scope of women's neurology spans across a woman's life including puberty, adolescence, peripartum care, menopause, and aging. Women's neurology is a new subspecialty that aligns with a specific patient population and intersects with established neurology subspecialties and other specialties such as obstetrics, maternal fetal medicine, endocrinology, and psychiatry. Its establishment and collaboration with existing and emerging fields enables a more comprehensive approach to neurologic illness through the lens of sex and gender. Women's neurology is rapidly evolving through increased focus at academic centers, including expanded women's neurology curricula, dedicated women's neurology fellowship programs, improved understanding of sex and gender issues in neurosciences, and expansion of therapeutic options. Herein, we describe the history of the women's neurology field, emerging need for women's neurology specialists, information about training and career opportunities, and future directions.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Emerging Subspecialties in Neurology: Women's Neurology. · full record | OpenQuestion